Dad Creates Website to Help Daughter Beat Rare Brain Cancer

A 29-year-old architect collapsed the day after presenting her graduate thesis and learned she had glioblastoma multiforme, one of the most aggressive brain cancers known. Doctors gave Shannon six to fourteen months to live.

Her father Eric, a French scientist living in Israel, had never been religious. But when the medical system said there was nothing left to do, he started searching for answers everywhere.

Through a network of strangers who read about Shannon's story online, Eric connected with Dr. Santosh Kesari in Santa Monica. The specialist identified targeted treatments for Shannon's specific genetic mutations that weren't available in Israel.

In March 2024, the family moved to Los Angeles. Surgeries removed 95% of the tumor, and experimental medications became available through unexpected channels.

After the first chemotherapy cycle, an MRI showed something no one expected: the tumor had shrunk. Shannon regained her ability to speak, eat solid food, and laugh again.

"If it hadn't happened to me, I wouldn't believe it," Eric said. "On one hand, it's impossible. On the other hand, it's happening."

Shannon's condition has since declined, but she's already survived far longer than her original prognosis. Eric, the rational scientist, couldn't stop asking one question: why did this combination of treatments work for Shannon when so few GBM patients survive?

The Ripple Effect

Eric realized that patients who beat the odds carry knowledge that could save others, but that information rarely makes it into medical studies. Healthcare institutions guard outcome data, physicians are overwhelmed, and rare success stories disappear one patient at a time.

So Eric teamed up with UCLA physician Dr. Todd Fineman and Emmy-nominated musician Peter Himmelman to create gbmoutlierstory.com. The website collects stories and data from GBM patients who have exceeded their prognoses.

The goal is simple: gather enough outlier cases to reveal patterns that clinical trials haven't explored yet. Every story submitted could contain the clue another family desperately needs.

The site is already collecting submissions from patients, caregivers, and physicians across the country. Each data point represents not just a statistic, but a real person who found a path forward when the standard treatment options ran out.

Families facing a GBM diagnosis now have a place to look for hope beyond the median survival statistics, and researchers have a growing database of real-world outcomes that might reveal new treatment approaches.